1.Name and nature of the underlying asset (e.g., land
located at Sublot XX, Lot XX, North District, Taichung City):
Taipei office:3F-1, No.3-1, Park Street, Nangang District, Taipei City
Kaohsiung office:12F-7, No.56, Minsheng 1st Road, Xinxing District,
2.Date of the occurrence of the event:2022/12/22
3.Transaction unit amount (e.g.XX square meters, equivalent
to XX ping), unit price, and total transaction price:
Office lease area:245.70 ping
Unit price(tax excluded):NT$ 1,398/ping/month.
Parking spaces(six for cars and eight for motorcycles):
Office lease area:18 ping.
Unit price(tax excluded):NT$600/ping/month.
Total amount of right-of-use assets:NT$9,041,735
4.Trading counterparty and its relationship to the
Company (if the trading counterparty is a natural
person and furthermore is not a related party of the
Company, the name of the trading counterparty is
not required to be disclosed):
Counterparty to the trade: TTY Biopharm Company Limited
Relationship with the Company: the Company's parent company.
5.Where the trading counterparty is a related party,
announcement shall also be made of the reason for
choosing the related party as trading counterparty and
the identity of the previous owner, its relationship with
the Company and the trading counterparty, and the
previous date and monetary value of transfer:
(1)Reason for choosing the related party as trading counterpart:
Operation need.(2)Previous owner, its relationship with the
Company and the trading counterparty,and the previous date and
monetary value of transfer: N/A
6.Where an owner of the underlying assets within the past
five years has been a related party of the Company, the
announcement shall also include the date and price of
acquisition and disposal by the related party, and its
relationship to the Company at the time of the
7.Projected gain (or loss) through disposal (not
applicable for acquisition of assets; those with deferral
should provide a table explaining recognition): N/A
8.Terms of delivery or payment (including payment period
and monetary value), restrictive covenants in the contract,
and other important terms and conditions:
(1)Payment term:Monthly rent is NT$ 383,050
(business tax excluded)Lease period:2023/1/1~2024/12/31.
In addition to the aforementioned lease payment, utilities and
management cost shall be allocated on the
basis of ping every month.
(2)Restrictive covenants in the contract: None.
9.The manner of deciding on this transaction (such as
invitation to tender, price comparison, or price
negotiation), the reference basis for the decision
on price, and the decision-making department:
(1)The manner of deciding on this transaction and the
reference basis for the decision on price: Based on market
price and negotiation.
(2)The decision-making department:Board of directors.
10.Name of the professional appraisal firm or company
and its appraisal price: N/A
11.Name of the professional appraiser: N/A
12.Practice certificate number of the professional
13.The appraisal report has a limited price, specific
price, or special price:N/A
14.An appraisal report has not yet been obtained:N/A
15.Reason for an appraisal report not being obtained:N/A
16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:N/A
17.Name of the CPA firm:N/A
18.Name of the CPA:N/A
19.Practice certificate number of the CPA:N/A
20.Broker and broker's fee:N/A
21.Concrete purpose or use of the acquisition or disposal:Office.
22.Any dissenting opinions of directors to the present
23.Whether the counterparty of the current transaction
is a related party:Yes.
24.Date of the board of directors’ resolution:2022/12/22
25.Date of ratification by supervisors or approval
by the audit committee:2022/12/22
26.The transaction is to acquire a real property or
right-of-use asset from a related party:Yes.
27.The price assessed in accordance with the Article
16 of the Regulations Governing the Acquisition and
Disposal of Assets by Public Companies:N/A
28.Where the above assessed price is lower than the
transaction price, the price assessed in accordance
with the Article 17 of the same regulations:N/A
29.Any other matters that need to be specified:None.